Product Information
FLUOXETINE 20 MG/5 ML SOLUTION is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.2033 per ML under NDC 00832603212. Its NADAC has been published 186 times since Mar 15, 2023.
FDA first approved this application on Nov 15, 2022. Its Orange Book therapeutic-equivalence code is AA.
Strength
20 mg/5mL
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832603212
Classification
Generic
Dosage Form
FOR SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLUOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216953FDA Approved
11/15/2022
TE Code
AA
On Market Since
11/15/2022
Pharmacological Classes
Price Statistics
The NADAC for FLUOXETINE 20 MG/5 ML SOLUTION has been published 186 times since Mar 15, 2023, and over the history we have for it it has declined 25.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2033 per ML |
|---|---|
| All-time high | $0.2839 (Dec 13, 2023) |
| All-time low | $0.1558 (Nov 20, 2024) |
| 52-week high | $0.2252 |
| 52-week low | $0.1913 |
| Median price | $0.2218 |
| Average price | $0.2286 |
| Largest weekly change | +41.9% (Aug 21, 2024) |
| Weeks tracked | 186 |
| Tracking since | Mar 15, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Fluoxetine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fluoxetine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUOXETINE 20 MG/5 ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for FLUOXETINE 20 MG/5 ML SOLUTION, manufactured by Upsher-Smith Laboratories LLC, is $0.2033 per ML (NDC 00832603212), effective Sep 30, 2026.
How has the price of FLUOXETINE 20 MG/5 ML SOLUTION changed over time?
Over the history we have for it, the NADAC for FLUOXETINE 20 MG/5 ML SOLUTION has declined 25.0%. It has been tracked across 186 weekly CMS publications since Mar 15, 2023.
What are the highest and lowest recorded NADAC prices for FLUOXETINE 20 MG/5 ML SOLUTION?
Since Mar 15, 2023, the NADAC for FLUOXETINE 20 MG/5 ML SOLUTION has ranged from a low of $0.1558 (Nov 20, 2024) to a high of $0.2839 (Dec 13, 2023), with a median of $0.2218 per ML.
Are there cheaper alternatives to FLUOXETINE 20 MG/5 ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of FLUOXETINE 20 MG/5 ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FLUOXETINE 20 MG/5 ML SOLUTION?
FLUOXETINE 20 MG/5 ML SOLUTION (NDC 00832603212) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.